WHITBY GROUP PRACTICE — All Prescriptions & Medications — Page 14
Practice Code: B82017 | WHITBY, YO21 1SD
Showing results 651-700 of 740
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hydroxycarbamide | 14 | 672 | £92 | -51.5% ▼ |
| Magnesium citrate | 14 | 714 | £1.1K | +93.6% ▲ |
| Tube feed non ACBS 1kcal/ml higher protein (0914061) | 14 | 172.0K | £2.1K | +231.1% ▲ |
| Ketoprofen | 14 | 750 | £33 | -61.0% ▼ |
| Sodium chloride | 14 | 49 | £627 | +111.5% ▲ |
| Erythromycin | 14 | 660 | £321 | +3.1% ▲ |
| 14 | 151 | £467 | -49.7% ▼ | |
| 14 | 55 | £1.3K | +54.3% ▲ | |
| 14 | 400 | £122 | -32.8% ▼ | |
| 14 | 400 | £1.3K | -13.6% ▼ | |
| Glyceryl trinitrate | 13 | 390 | £478 | -2.2% ▼ |
| Chlortalidone | 13 | 182 | £359 | +31.8% ▲ |
| Celiprolol hydrochloride | 13 | 364 | £231 | -1.7% vs avg |
| Clonidine hydrochloride | 13 | 728 | £52 | -28.8% ▼ |
| Inclisiran | 13 | 13 | £611 | +3.2% ▲ |
| Flupentixol hydrochloride | 13 | 728 | £98 | -40.7% ▼ |
| Doxepin | 13 | 364 | £1.2K | +0.0% vs avg |
| Atomoxetine hydrochloride | 13 | 728 | £1.4K | -61.6% ▼ |
| Phenobarbital | 13 | 364 | £11 | -57.7% ▼ |
| Linagliptin/metformin | 13 | 728 | £411 | -61.4% ▼ |
| Liothyronine sodium | 13 | 364 | £881 | -39.1% ▼ |
| Betamethasone sodium phosphate | 13 | 776 | £105 | +5.7% ▲ |
| Dienogest | 13 | 364 | £253 | +79.5% ▲ |
| Metronidazole | 13 | 560 | £57 | +96.6% ▲ |
| Cinacalcet hydrochloride | 13 | 406 | £103 | -44.0% ▼ |
| Tizanidine hydrochloride | 13 | 1,050 | £45 | -50.9% ▼ |
| Cholera | 13 | 14 | £325 | +180.7% ▲ |
| 13 | 276 | £811 | +102.4% ▲ | |
| 13 | 260 | £65 | -11.6% ▼ | |
| 13 | 900 | £735 | -60.7% ▼ | |
| 13 | 1,450 | £290 | -49.6% ▼ | |
| 13 | 780 | £2.2K | -12.1% ▼ | |
| 13 | 780 | £2.8K | -65.4% ▼ | |
| Prednisolone | 12 | 272 | £29 | -83.3% ▼ |
| Terazosin hydrochloride | 12 | 315 | £23 | -26.2% ▼ |
| Olmesartan medoxomil/hydrochlorothiazide | 12 | 336 | £200 | +21.0% ▲ |
| Pentoxifylline | 12 | 360 | £75 | -4.2% ▼ |
| Trifluoperazine | 12 | 1,800 | £933 | -20.4% ▼ |
| Fluvoxamine maleate | 12 | 354 | £169 | -1.3% vs avg |
| Oxcarbazepine | 12 | 1,440 | £627 | -57.1% ▼ |
| Soluble insulin (Neutral insulin) | 12 | 75 | £526 | +24.6% ▲ |
| Solifenacin/tamsulosin | 12 | 360 | £295 | -41.6% ▼ |
| Fesoterodine fumarate | 12 | 336 | £29 | -69.6% ▼ |
| Powder extensively hydrolysed formula (0913132) | 12 | 14.0K | £405 | +113.5% ▲ |
| Tube feed additive 0.5 kcal/ml high fibre liquid (0914052) | 12 | 19.5K | £709 | +24.5% ▲ |
| Antazoline | 12 | 120 | £38 | +170.1% ▲ |
| Dexamethasone sodium metasulphobenzoate | 12 | 96 | £85 | +61.5% ▲ |
| Flumetasone pivalate | 12 | 105 | £150 | +179.1% ▲ |
| Other treatment of dry mouth preparations | 12 | 1,200 | £26 | +82.7% ▲ |
| Tars | 12 | 2,975 | £173 | +43.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.